Commercial application of carrier silica gel

• Publisher: Elsevier Science
• Year: 2006
• Weight: 44 KB
• Volume: 2006
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(06)71573-2

✦ Synopsis

emission control technologies to pharmaceutical production. The alliance will involve the re-development of the new series of palladiumcontaining perovskite (Pd-perovskite) catalysts, initially formulated by Hokko for high-efficiency catalytic converters, for organic chemistry applications. Reaxa intends to develop Pdperovskites for pharmaceuticals and fine chemical synthesis applications and to use these new and highly active catalysts in drug process development and scale-up. The agreement will provide Reaxa exclusive commercialisation rights for Hokko's perovskite catalyst line for use in organic chemistry outside Japan.